Caxton Associates (New York)’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-27,369	Closed	-$1.48M	–	483
2024 Q1	$1.48M	Buy	27,369 +1,430	+6%	+$72.8K	0.1%	168
2023 Q4	$1.33M	Hold	25,939	–	–	0.07%	186
2023 Q3	$1.51M	Buy	25,939 +14,204	+121%	+$870K	0.21%	85
2023 Q2	$750K	Buy	11,735 +1,771	+18%	+$119K	0.11%	191
2023 Q1	$691K	Sell	9,964 -15,940	-62%	-$1.12M	0.11%	208
2022 Q4	$1.86M	Buy	+25,904	New	+$1.95M	0.14%	48
2022 Q3	–	Sell	-8,082	Closed	-$622K	–	492
2022 Q2	$622K	Buy	+8,082	New	+$616K	0.08%	220
2020 Q3	–	Sell	-11,019	Closed	-$648K	–	329
2020 Q2	$648K	Buy	+11,019	New	+$659K	0.06%	99
2018 Q2	–	Sell	-4,572	Closed	-$289K	–	383
2018 Q1	$289K	Buy	+4,572	New	+$294K	0.03%	291
2017 Q3	–	Sell	-6,600	Closed	-$368K	–	499
2017 Q2	$368K	Buy	+6,600	New	+$359K	0.03%	419